← Back to patent-cliff list
CAS 16475-90-4
methyl 5-acetyl-2-hydroxybenzoate
Codes：SALM-019
Application context (from source-drug indications)
哮喘布地奈德/昔萘酸沙美特罗
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 布地奈德/昔萘酸沙美特罗Budesonide/Salmeterol xinafoate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1,6-dibromohexane→4-phenylbutan-1-ol→(4-((6-bromohexyl)oxy)butyl)benzene→N-benzyl-6-(4-phenylbutoxy)hexan-1-amine hydrochloride→methyl 2-(benzyloxy)-5-(2-bromoacetyl)benzoate→methyl 5-(2-(benzyl(6-(4-phenylbutoxy)hexyl)amino)acetyl)-2-(benzyloxy)benzoate→2-(benzyl(6-(4-phenylbutoxy)hexyl)amino)-1-(4-(benzyloxy)-3-(hydroxymethyl)phenyl)ethanol→methyl 5-acetyl-2-hydroxybenzoate→methyl 5-acetyl-2-(benzyloxy)benzoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.